Talotrexin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Talotrexin, covering 2014-08-08 to 2014-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment [Phase 1]